Pet Healthcare Market in Japan to 2014

Introduction

This databook provides key data and information on the pet healthcare market in Japan. This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

• Contains information on five categories:external parasite treatments, worming treatments, grooming products, other pet healthcare and pet supplements
• Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2004-09) and forecast (2010-14) data
• Category level company and brand share as well as distribution share information for 2008 and 2009
• Review of the top two companies within the pet healthcare market, including company overview, key facts and business description

Highlights

• The market for pet healthcare in Japan increased at a compound annual growth rate of 3.1% between 2004 and 2009.
• The external parasite treatments category led the pet healthcare market in Japan, accounting for a share of 24.4%.
• The leading players in the Japanese pet healthcare market include Novartis AG, Pfizer Inc and DoggyMan H. A. Co. Ltd.

Reasons to Purchase

• Develop business strategies by understanding the quantitative trends within the pet healthcare market in Japan
• Design effective marketing and sales strategies by identifying key market categories and segments
• Identify key players within the market to plan lucrative M&A, partnerships and agreements